Researchers to present award lectures at San Antonio Breast Cancer Symposium
Click Here to Manage Email Alerts
The San Antonio Breast Cancer Symposium and American Association for Cancer Research will honor two breast cancer researchers for their contributions to the field.
Susan E. Hankinson, ScD, MPH, will receive the AACR Distinguished Lectureship in Breast Cancer Research award, supported by Aflac Inc.
Sherene Loi, MD, PhD, will receive the AACR Outstanding Investigator Award for Breast Cancer Research, supported by Breast Cancer Research Foundation.
“These researchers have greatly contributed to our understanding of breast cancer etiology, development and recurrence. Their findings have helped to inform new methods of prevention and treatment that hold great promise for patients,” Carlos Arteaga, MD, FAACR, director of Harold C. Simmons Comprehensive Cancer Center at UT Southwestern and past president of AACR, said in a press release. “We applaud Dr. Hankinson and Dr. Loi for their hard work and dedication and are thrilled to honor them with these awards at this year’s SABCS.”
Hankinson is distinguished professor of epidemiology and associate dean for research at University of Massachusetts Amherst’s School of Public Health and Health Sciences.
She will be recognized for research contributions that yielded insights into the hormonal etiology of breast cancer.
Her investigations into the role of circulating estrogens in predicting breast cancer risk helped lead to the development of chemopreventive drugs and improved the understanding of how lifestyle modifications can reduce breast cancer risk.
Harkinson’s lecture will be titled “Biomarkers in population-based breast cancer research: Insights into etiology and risk prediction.”
Loi is consultant medical oncologist and medical oncology trial lead for breast cancer at Parkville Cancer Clinical Trials Unit, head of the translational breast cancer genomics and therapeutics laboratory at Peter MacCallum Cancer Centre in Australia, and professor at University of Melbourne.
Loi will be recognized for her efforts to integrate translational research into clinical trials, and to incorporate immunotherapies into breast cancer treatment.
Her research focuses on how the interaction interaction between the immune landscape and breast cancer genome relates to treatment resistance and response. She also has investigated the biological and clinical relevance of tumor-infiltrating lymphocytes in breast cancer.
Loi’s award lecture will be titled “Journey into breast cancer immunology using genomics.”
Click Here to Manage Email Alerts